Varian Medical Systems

Varian Medical Systems Inc.

Type	Public
Traded as	: VAR S&P 500 Component
Industry	Medical Technology
Founded	1948; 69 years ago (1948)
Headquarters	Palo Alto, California, U.S.
Key people	Dow R. Wilson, President and CEO
Products	Medical Devices
Revenue	US$ 2,942.897 million (2013) US$ 2,807.015 million (2012)
Operating income	US$ 608.89 million (2013) US$ 594.074 million (2012)
Net income	US$ 438.248 million (2013) US$ 427.049 million (2012)
Total assets	US$ 3,468.474 million (2013) US$ 2,878.726 million (2012)
Total equity	US$ 1,713.847 million (2013) US$ 1,509.776 million (2012)
Number of employees	6,350
Website	www.varian.com

Varian Medical Systems (VAR) of Palo Alto, California, USA, is a leading radiation oncology treatments and software maker. These medical devices include linear accelerators and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies software for managing comprehensive cancer clinics, radiotherapy centers, and medical oncology practices. Varian is a supplier of tubes and digital detectors for X-ray imaging in medical diagnostics, dentistry, veterinary care, scientific, security, industrial inspection including high-energy X-ray technology for cargo screening. Varian Medical Systems employs approximately 6,350 people at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world.

Varian was founded in 1948 as Varian Associates by Russell H. Varian, Sigurd F. Varian, William Webster Hansen, and Edward Ginzton to sell the Klystron, the first tube which could generate electromagnetic waves at microwave frequencies, and other electromagnetic equipment.

By 1999, Varian Associates had branched into semiconductor, vacuum tube, and medical device fields. On April 2, 1999 these divisions split to become Varian Semiconductor, Varian, Inc. and Varian Medical Systems.

Varian corporate headquarters is in Palo Alto, California. In September 2012, Dow Wilson replaced Timothy Guertin as President and CEO. Guertin had been the CEO since 2006 when he replaced Richard M. Levy, who had been with Varian for 37 years and still serves as chairman of the board of directors. Wilson is a graduate of Brigham Young University, and holds an MBA from the Amos Tuck School of Business at Dartmouth.